期刊文献+

锂盐在精神疾病中的应用 被引量:3

The application of lithium in mental disorder
下载PDF
导出
摘要 锂盐作为情绪稳定剂用于治疗双相情感障碍已有60多年的历史,大量研究证明锂盐用于治疗急性躁狂以及对预防双相情感障碍的反复发作有效。锂盐还具有独特的预防自杀风险的效应,可降低情感障碍患者的自杀风险。最近锂盐在神经精神方面的应用研究有了新的进展,其独特的机制更是在不同的领域中被发现并应用,锂盐通过作用于GSK-3的抑制来发挥神经保护作用,这种保护作用对神经退行性疾病阿尔茨海默病、帕金森病、亨廷顿病的防治具有潜在用途。几个旨在评估锂盐对这些疾病疗效的临床试验正在进行中。 Lithium as a mood stabilizer has been used in the standard pharmacological treatment of bipolar disorder (BD) for more than 60 years. It remains to be recommended by many treatment guidelines as the ifrst-line treatment for acute mania, and prophylactically for recurrent manic and depressive episodes. Lithium can help prevent suicide and is associated with a lower risk for all-cause mortality in patients with mood disorders. Evidence from preclinical studies suggests that neuroprotection induced by lithium is mainly related to its potent inhibition of the enzyme glycogen synthase kinase-3 (GSK-3) and its downstream effects, which may have a potential use in the treatment of a wide variety of neurodegenerative disorders such as Alzheimer’s, Parkinson’s and Huntington’s diseases. Several clinical trials are also underway to assess the therapeutic effects of lithium on these disorders.
作者 陈华 季建林
出处 《上海医药》 CAS 2014年第19期9-12,共4页 Shanghai Medical & Pharmaceutical Journal
关键词 锂盐 情绪稳定剂 神经保护 神经营养 精神障碍 lithium mood stabilizers neuroprotective neurotrophic mental disorders
  • 相关文献

参考文献12

  • 1Shorter E. The history of lithium therapy[J]. Bipolar Disord, 2009, 11( Suppl 2): 4-9.
  • 2Baldessarini R J, Tondo L, Davis P, et al. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review[J]. Bipolar Disord, 2006, 8(5 Pt 2): 625- 639.
  • 3Goodwin FK. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder[J]. J Clin Psychiatry, 2003, 64 (Suppl 5): 18-24.
  • 4Cipriani A, Pretty H, Hawton K, et al. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials[J]. Am J Psychiatry, 2005, 162(10): 1805- 1819.
  • 5Chuang, DM. The antiapoptotic actions of mood stabilizers:molecular mechanisms and therapeutic potentials[J]. Ann N Y Acad Sci, 2005, 1053: 195-204.
  • 6Goodwin, GM, Geddes JR. Latest maintenance data on lithium in bipolar disorder[J]. Eur Neuropsychopharmacol, 2003, 13 (Suppl 2): $51-$55.
  • 7Nierenberg AA, Friedman ES, Bowden CL, et al. Lithium treatment moderate-dose use study (LITMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium[J]. Am J Psychiatry, 2013, 170(1): 102-110.
  • 8Malhi GS, Tanious M, Das P, et al. Potential mechanisms of action of lithium in bipolar disorder. Current understanding[J]. CNS Drugs, 2013, 27(2): 135-153.
  • 9Chiu CT, Chuang DM. Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders[J]. Pharmacol Ther, 2010. 128(2): 281-304.
  • 10Cipriani A, Girlanda F, Agrimi E, et al. Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial[J/OL]. BMC Psychiatry, 2013, 13:212 [2014-01- 07]. http://www.biomedcentral.com/content/pdf/1471- 244X-13-212.pdf.

同被引文献28

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部